99mTc MAG3 scintigraphy in a patient with hyperacute antibody mediated Rejection: A description of the correlation between image findings and clinical disease process.
Background: Hyperacute antibody mediated rejection (HA-AMR) occurs within 24 h after a renal transplant. Technetium-99m Mercaproacetyl triglicine (99mMAG3) scintigraphy is rarely done within this time period and clinicians rely on clinical features and laboratory parameters for diagnosis. To date li...
Main Authors: | A. Isah, R. Steyn, Z. Barday, F.C.J. Botha |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Transplantation Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S245195961930006X |
Similar Items
-
Comparison of 99mTc-DMSA, 99mTc-DTPA and 99mTc-MAG3 Renal Scintigraphy in the Calculation of Relative Renal Function
by: Fadime Demir, et al.
Published: (2020-06-01) -
Comparison of relative renal function measured with either 99mTc-DTPA or 99mTc-EC dynamic scintigraphies with that measured with 99mTc-DMSA static scintigraphy
by: F. C. Domingues, et al.
Published: (2006-08-01) -
Head to head comparison of [99mTc]Tc(CO)3(NTA) and [99mTc]Tc-MAG3 in patients with suspected obstruction
by: Andrew T. Taylor, et al.
Published: (2021-05-01) -
The role of 99mTc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with 99mTc-MIBI planar scintigraphy and ultrasonography
by: Shu-Qin Jiang, et al.
Published: (2020-10-01) -
Validity of dual tracer 99mTc-tetrofosmin and 99mTc-pertechnetate subtraction parathyroid scintigraphy in patients with primary and secondary hyperparathyroidism
by: Dugonjić Sanja, et al.
Published: (2009-01-01)